Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Supporting self-care for eczema in the community: the Eczema Care Online research programme including two RCTs›References

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Supporting self-care for eczema in the community: the Eczema Care Online research programme including two RCTs · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 11 min read

  1. Chamlin SL, Frieden IJ, Williams ML, Chren MM. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004;114:607–11. 10.1542/peds.2004-037415342828
  2. Muller I, Stuart B, Sach T, Hooper J, Wilczynska S, Steele M, et al. Supporting self-care for eczema: protocol for two randomised controlled trials of ECO (Eczema Care Online) interventions for young people and parents/carers. BMJ Open 2021;11:e045583. 10.1136/bmjopen-2020-045583
  3. Noerreslet M, Jemec GBE, Traulsen JM. Involuntary autonomy: patients’ perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis. Soc Sci Med 2009;69:1409–15. 10.1016/j.socscimed.2009.08.03619762137
  4. Mollerup A, Johansen JD, Thing LF. Knowledge, attitudes and behaviour in everyday life with chronic hand eczema: a qualitative study. Br J Dermatol 2013;169:1056–65. 10.1111/bjd.1252423889257
  5. Olabi B, Williams HC. Evidence-based management of eczema: five things that should be done more and five things that should be dropped. Curr Opin Allergy Clin Immunol 2021;21:386–93. 10.1097/ACI.000000000000075033993140
  6. de Wijs LE, van Egmond S, Devillers AC, Nijsten T, Hijnen D, Lugtenberg M. Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study. Arch Dermatol Res 2022;315:1–9. 10.1007/s00403-021-02321-z34999934
  7. Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol 2003;28:549–53. 10.1046/j.1365-2230.2003.01357.x12950351
  8. Santer M, Burgess H, Yardley L, Ersser SJ, Lewis‐Jones S, Muller I, et al. Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs 2013;69:2493–501. 10.1111/jan.1213323528163
  9. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000;142:931–6. 10.1046/j.1365-2133.2000.03473.x10809850
  10. Santer M, Burgess H, Yardley L, Ersser S, Lewis-Jones S, Muller I, et al. Experiences of carers managing childhood eczema and their views on its treatment: a qualitative study. Br J Gen Pract 2012;62:e261–7. 10.3399/bjgp12X63608322520913
  11. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLOS One 2013;8:e80633. 10.1371/journal.pone.008063324312488
  12. Santer M, Muller I, Yardley L, Burgess H, Ersser SJ, Lewis-Jones S, Little P. ‘You don’t know which bits to believe’: qualitative study exploring carers’ experiences of seeking information on the internet about childhood eczema. BMJ Open 2015;5:e006339. 10.1136/bmjopen-2014-006339
  13. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR; International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008;121:947–54.e15. 10.1016/j.jaci.2007.11.00418155278
  14. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014;134:1527–34. 10.1038/jid.2013.44624166134
  15. Silverwood RJ, Mansfield KE, Mulick A, Wong AYS, Schmidt SAJ, Roberts A, et al. Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998–2016. J Allergy Clin Immunol 2021;147:1753–63. https://doi.org/0.1016/j.jaci.2020.12.0033516523
  16. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006;155:145–51. 10.1111/j.1365-2133.2006.07185.x16792766
  17. Ring J, Zink A, Arents B, Seitz IA, Mensing U, Schielein MC, et al. Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults. J Eur Acad Dermatol Venereol 2019;33:1331–40. 10.1111/jdv.1563431002197
  18. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004;150:284–90. 10.1111/j.1365-2133.2004.05776.x14996099
  19. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008;25:1–6. 10.1111/j.1525-1470.2007.00572.x
  20. Kemp AS. Cost of illness of atopic dermatitis in children: a societal perspective. PharmacoEconomics 2003;21:105–13. 10.2165/00019053-200321020-0000312515572
  21. Thomas K, Koller K, Dean T, O’Leary CJ, Sach TH, Frost A, et al. A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technol Assess 2011;15:156. 10.3310/hta15080
  22. Thomas KS, Bradshaw LE, Sach TH, Cowdell F, Batchelor JM, Lawton S, et al. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial. Health Technol Assess 2017;21:1–260. 10.3310/hta21160
  23. Staab D, von Rueden U, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, Wahn U. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002;13:84–90. 10.1034/j.1399-3038.2002.01005.x12000479
  24. Global Patient Initiative to Improve Eczema Care. A Global Measure Dashboard of Patient-centered Eczema Care. URL: www.improveeczemacare.com/dashboard (accessed February 2022).
  25. Batchelor JM, Ridd MJ, Clarke T, Ahmed A, Cox M, Crowe S, et al. The Eczema Priority Setting Partnership: a collaboration between patients, carers, clinicians and researchers to identify and prioritize important research questions for the treatment of Eczema. Br J Dermatol 2013;168:577–82. 10.1111/bjd.1204022963149
  26. Teasdale E, Muller I, Sivyer K, Ghio D, Greenwell K, Wilczynska S, et al. Views and experiences of managing eczema: systematic review and thematic synthesis of qualitative studies. Br J Dermatol 2021;184:627–37. 10.1111/bjd.1929932531800
  27. Capozza K. Never the twain shall meet? Bridging the divide between patient perspectives and health professionals and systems. Br J Dermatol 2021;184:587–8. 10.1111/bjd.19545
  28. Signal N. Addressing misconceptions about eczema could help people manage their condition over the long term [Internet]. National Institute for Health Research; 2020 Dec. 10.3310/alert_42973
  29. Ghio D, Muller I, Greenwell K, Roberts A, McNiven A, Langan SM, Santer M. ‘It’s like the bad guy in a movie who just doesn’t die’: a qualitative exploration of young people’s adaptation to eczema and implications for self‐care. Br J Dermatol 2020;182:112–8. 10.1111/bjd.1804631021418
  30. Ghio D, Greenwell K, Muller I, Roberts A, McNiven A, Santer M. Psychosocial needs of adolescents and young adults with eczema: a secondary analysis of qualitative data to inform a behaviour change intervention. Br J Health Psychol 2021;26:214–31. 10.1111/bjhp.1246732844574
  31. Greenwell K, Ghio D, Muller I, Roberts A, McNiven A, Lawton S, Santer M. Taking charge of eczema self-management: a qualitative interview study with young people with eczema. BMJ Open 2021;11:e044005. 10.1136/bmjopen-2020-044005
  32. Teasdale E, Sivyer K, Muller I, Ghio D, Roberts A, Lawton S, Santer M. Children’s views and experiences of treatment adherence and parent/child co-management in eczema: a qualitative study. Children 2021;8:158. 10.3390/children802015833672514
  33. Clark A. Listening to Young Children, Expanded Third Edition: A Guide to Understanding and Using the Mosaic Approach. London: Jessica Kingsley Publishers, 2017.
  34. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 10.1191/1478088706qp063oa
  35. Sivyer K, Teasdale E, Greenwell K, Steele M, Ghio D, Ridd MJ, et al. Supporting families managing childhood eczema: developing and optimising Eczema Care Online using qualitative research. Br J Gen Pract 2022;72:e378–89. 10.3399/BJGP.2021.050335577586
  36. Axon E, Chalmers JR, Santer M, Ridd MJ, Lawton S, Langan SM, et al. Safety of topical corticosteroids in atopic eczema: an umbrella review. BMJ Open 2021;11:e046476. 10.1136/bmjopen-2020-046476
  37. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008. 10.1136/bmj.j400828935701
  38. Lax SJ, Harvey J, Axon E, Howells L, Santer M, Ridd MJ, et al. Strategies for using topical corticosteroids in children and adults with eczema. Cochrane Database Syst Rev 2022;3:CD013356. 10.1002/14651858.CD013356.pub235275399
  39. Thomas K, Apfelbacher C, Chalmers J, Simpson E, Spuls PI, Gerbens LAA, et al. Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting. Br J Dermatol 2021;185:139–46. 10.1111/bjd.1975133393074
  40. Bowie AC, Tadrous M, Egeberg A, Harvey J, Lax SJ, Thyssen JP, Drucker AM. Agreement and correlation between different topical corticosteroid potency classification systems. JAMA Dermatol 2022;158:796–800. 10.1001/jamadermatol.2022.170635612864
  41. Harvey J, Lax SJ, Lowe A, Santer M, Lawton S, Langan SM, et al. The long‐term safety of topical corticosteroids in atopic dermatitis: a systematic review. Skin Health Dis 2023;3:e268. 10.1002/ski2.26837799373
  42. Greenwell K, Ghio D, Sivyer K, Steele M, Teasdale E, Ridd MJ, et al. Eczema Care Online: development and qualitative optimisation of an online behavioural intervention to support self-management in young people with eczema. BMJ Open 2022;12:e056867. 10.1136/bmjopen-2021-056867
  43. Muller I, Santer M, Morrison L, Morton K, Roberts A, Rice C, et al. Combining qualitative research with PPI: reflections on using the person-based approach for developing behavioural interventions. Res Involv Engagem 2019;5:1–8. 10.1186/s40900-019-0169-830788147
  44. Yardley L, Morrison L, Bradbury K, Muller I. The person-based approach to intervention development: application to digital health-related behavior change interventions. J Med Internet Res 2015;17:e30. 10.2196/jmir.405525639757
  45. Morrison L, Muller I, Yardley L, Bradbury K. The person-based approach to planning, optimising, evaluating and implementing behavioural health interventions. Eur Health Psychol 2018;20:464–9.
  46. Yardley L, Ainsworth B, Arden-Close E, Muller I. The person-based approach to enhancing the acceptability and feasibility of interventions. Pilot Feasibility Stud 2015;1:1–7. 10.1186/s40814-015-0033-z29611687
  47. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46:81–95. 10.1007/s12160-013-9486-623512568
  48. Michie S, Atkins L, West R. The Behaviour Change Wheel. A Guide to Designing Interventions. 1st edn. Great Britain: Silverback Publishing; 2014.
  49. Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci 2017;12:1–18. 10.1186/s13012-017-0605-928057027
  50. Bradbury K, Morton K, Band R, van Woezik A, Grist R, McManus RJ, et al. Using the person-based approach to optimise a digital intervention for the management of hypertension. PLOS One 2018;13:e0196868. 10.1371/journal.pone.019686829723262
  51. Williams S, Yardley L, Weal M, Wills G. Introduction to LifeGuide: open-source software for creating online interventions for health care, health promotion and training. 2010:187–90.
  52. Santer M, Muller I, Becque T, Stuart B, Hooper J, Steele M, et al. Eczema Care Online behavioural interventions to support self-care for children and young people: two independent, pragmatic, randomised controlled trials. BMJ 2022;379:e072007. 10.1136/bmj-2022-07200736740888
  53. Sach TH, Onoja M, Clarke H, Santer M, Muller I, Becque T, et al. Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people. Eur J Health Econ 2024;25:1165–76. 10.1007/s10198-023-01649-938194207
  54. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure. development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol 2004;140:1513–9. 10.1001/archderm.140.12.151315611432
  55. Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating patient-oriented eczema measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol 2013;169:1326–32. 10.1111/bjd.1259024024631
  56. Howells LM, Chalmers JR, Gran S, Ahmed A, Apfelbacher C, Burton T, et al. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: recap of atopic eczema (RECAP). Br J Dermatol 2020;183:524–36. 10.1111/bjd.1878031794074
  57. Yosipovitch G, Reaney M, Mastey V, Eckert L, Abbé A, Nelson L, et al. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis. Br J Dermatol 2019;181:761–9. 10.1111/bjd.1774430729499
  58. Howie JG, Heaney DJ, Maxwell M, Walker JJ. A comparison of a Patient Enablement Instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations. Fam Pract 1998;15:165–71. 10.1093/fampra/15.2.1659613486
  59. Stevens K. Valuation of the Child Health Utility 9D Index. PharmacoEconomics 2012;30:729–47. 10.2165/11599120-000000000-0000022788262
  60. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. 10.1007/s11136-011-9903-x21479777
  61. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Ann Intern Med 2017;167:40–7. 10.7326/m17-00428630973
  62. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. 10.1136/bmj.c33220332509
  63. Tate DF, Finkelstein EA, Khavjou O, Gustafson A. Cost effectiveness of internet interventions: review and recommendations. Ann Behav Med 2009;38:40–5. 10.1007/s12160-009-9131-619834778
  64. Jones K. Unit Costs of Health and Social Care 2021. 2021. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-of-health-and-social-care-2021/ (accessed 5 December 2022).
  65. NHS Business Services Authority. Prescription Cost Analysis – England 2020–21. 2021. URL: www.nhsbsa.nhs.uk/statistical-collections/prescription-cost-analysis-england/prescription-cost-analysis-england-202021 (accessed 30 November 2022).
  66. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. London, UK: National Institute for Health and Clinical Excellence (NICE); 2013.
  67. van Hout B, Janssen M, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.00822867780
  68. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96. 10.1002/hec.94415497198
  69. Howells L, Ratib S, Chalmers J, Bradshaw L, Thomas KS; the CLOTHES trial team. How should minimally important change scores for the Patient‐Oriented Eczema Measure be interpreted? A validation using varied methods. Br J Dermatol 2018;178:e354–e354. 10.1111/bjd.16367
  70. Willan AR, Briggs AH, Hoch JS. Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data. Health Econ 2004;13:461–75. 10.1002/hec.84315127426
  71. Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics 2014;32:1157–70. 10.1007/s40273-014-0193-325069632
  72. Paulden M. Calculating and interpreting ICERs and net benefit. PharmacoEconomics 2020;38:785–807. 10.1007/s40273-020-00914-632390067
  73. Greenwell K, Sivyer K, Howells L, Steele M, Ridd MJ, Roberts A, et al. ‘Eczema shouldn’t control you; you should control eczema’: qualitative process evaluation of online behavioural interventions to support young people and parents/carers of children with eczema. Br J Dermatol 2022;188:506–13. 10.1093/bjd/ljac115
  74. Steele M, Howells L, Santer M, Sivyer K, Lawton S, Roberts A, et al. How has the COVID‐19 pandemic affected eczema self‐management and help seeking? A qualitative interview study with young people and parents/carers of children with eczema. Skin Health Dis 2021;1:e59. 10.1002/ski2.5934514465
  75. Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health 2019;11:589–97. 10.1080/2159676X.2019.1628806
  76. Santer M, Yardley L, Muller I, Roberts A, Thomas KS. How to make Eczema Care Online freely available. BMJ 2022;8:379. 10.1136/bmj.o2973
  77. Ashrafzadeh S, Metlay JP, Choudhry NK, Emmons KM, Asgari MM. Using implementation science to optimize the uptake of evidence-based medicine into dermatology practice. J Invest Dermatol 2020;140:952–8. 10.1016/j.jid.2019.10.01131862108
  78. May C, Finch T, Mair F, Ballini L, Dowrick C, Eccles M, et al. Understanding the implementation of complex interventions in health care: the normalization process model. BMC Health Serv Res 2007;7:1–7. 10.1186/1472-6963-7-14817199886
  79. May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, et al. Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci 2009;4:1–9. 10.1186/1748-5908-4-2919123945
  80. Treweek S, Banister K, Bower P, Cotton S, Devane D, Gardner HR, et al. Developing the INCLUDE Ethnicity Framework – a tool to help trialists design trials that better reflect the communities they serve. Trials 2021;22:337. 10.1186/s13063-021-05276-833971916
  81. Kim RW, Barta K, Begolka WS, Capozza K, Eftekhari S, Tullos K, et al. Qualitative analysis of the impact of atopic dermatitis on caregivers. Br J Dermatol 2022;187:1038–41. 10.1111/bjd.2182835972353
← Implications for practice and lessons learntAdditional information →

Attribution. Ingrid Muller; Beth Stuart; Tracey Sach; Lucy Yardley; Kate Greenwell; Taeko Becque et al. (2025). Supporting self-care for eczema in the community: the Eczema Care Online research programme including two RCTs. National Institute for Health and Care Research. Copyright © 2025 Muller et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK613110. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support